Ji, Linong

Prevalence of Diabetes among Men and Women in China

Yang, W., Lu, J., Weng, J., Jia, W., Ji, L., Xiao, J., Shan, Z., Liu, J., Tian, H., Ji, Q., et al. (2010) · New England Journal of Medicine

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 3,031

Incidence of type 1 diabetes in China, 2010-13: population based study

Weng, J., Zhou, Z., Guo, L., Zhu, D., Ji, L., Luo, X., Mu, Y., & Jia, W. (2018) · BMJ

Diabetes and associated disordersDiabetes Management and Research

Cited by 316

Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis

Sun, F., Wu, S., Guo, S., Yu, K., Yang, Z., Li, L., Zhang, Y., Quan, X., Ji, L., & Zhan, S. (2015) · Diabetes Research and Clinical Practice

Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 304

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort

Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., et al. (2014) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 296

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

Klonoff, D. C., Wang, J., Rodbard, D., Kohn, M. A., Li, C., Liepmann, D., Kerr, D., Ahn, D., Peters, A. L., Umpierrez, G. E., et al. (2023) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchDiabetes Management and Education

Cited by 295

New insulin delivery recommendations

Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., Smith, M. J., Wellhoener, R., Bode, B. W., Hirsch, I. B., et al. (2016) · Mayo Clinic Proceedings

Diabetes Management and ResearchDiabetes Management and Education

Cited by 286

Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study)

Zhou, Z., Xiang, Y., Ji, L., Jia, W., Ning, G., Huang, G., Yang, L., Lin, J., Liu, Z., Hagopian, W. A., et al. (2013) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 251

Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis

Sun, F., Wu, S., Wang, J., Guo, S., Chai, S., Yang, Z., Li, L., Zhang, Y., Ji, L., & Zhan, S. (2015) · Clinical Therapeutics

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 232

Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

Sun, F., Chai, S., Yu, K., Quan, X., Yang, Z., Wu, S., Zhang, Y., Ji, L., Wang, J., & Shi, L. (2015) · Diabetes Technology & Therapeutics

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 158

COVID-19 in people living with diabetes: An international consensus

Caballero, A. E., Ceriello, A., Misra, A., Aschner, P., McDonnell, M. E., Hassanein, M., Ji, L., Mbanya, J. C., & Fonseca, V. A. (2020) · Journal of Diabetes and its Complications

COVID-19 Clinical Research StudiesDiabetes Management and Research

Cited by 132

Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China : A 30‐week, double‐blind, phase 3a, randomized trial

Ji, L., Dong, X., Li, Y., Li, Y., Lim, S., Liu, M., Ning, Z., Rasmussen, S., Skjøth, T. V., Yuan, G., et al. (2021) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 113

Dorzagliatin monotherapy in chinese patients with type 2 diabetes: A dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study

Zhu, D., Gan, S., Liu, Y., Ma, J., Dong, X., Song, W., Zeng, J., Wang, G., Zhao, W., Zhang, Q., et al. (2018) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 96

Efficacy and safety of mazdutide in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial

Zhang, B., Cheng, Z., Chen, J., Zhang, X., Liu, D., Jiang, H., Ma, G., Wang, X., Gan, S., Sun, J., et al. (2024) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 91

Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis

Sun, F., Yu, K., Yang, Z., Wu, S., Zhang, Y., Shi, L., Ji, L., & Zhan, S. (2012) · Experimental Diabetes Research

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 58

Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus

Pleus, S., Freckmann, G., Schauer, S., Heinemann, L., Ziegler, R., Ji, L., Mohan, V., Calliari, L. E., & Hinzmann, R. (2022) · Diabetes Therapy

Diabetes Management and ResearchDiabetes Management and Education

Cited by 55

Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis

Sun, F., Wu, S., Guo, S., Yu, K., Yang, Z., Li, L., Zhang, Y., Ji, L., & Zhan, S. (2015) · Endocrine

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 44

Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes

Cai, X., Shi, L., Yang, W., Gu, S., Chen, Y., Nie, L., & Ji, L. (2019) · Journal of Medical Economics

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 37

Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications

Wu, H., Yang, W., Guo, T., Cai, X., & Ji, L. (2025) · BMC Medicine

Pharmacology and Obesity TreatmentObesity, Physical Activity, Diet

Cited by 36

Multicenter Evaluation Study Comparing a New Factory-Calibrated Real-Time Continuous Glucose Monitoring System to Existing Flash Glucose Monitoring System

Ji, L., Guo, L., Zhang, J., Li, Y., & Chen, Z. (2023) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchElectrochemical sensors and biosensors

Cited by 26

Relationship between healthy lifestyle behaviors and cardiovascular risk factors in Chinese patients with type 2 diabetes mellitus: a subanalysis of the CCMR-3B STUDY

on behalf of CCMR-3B STUDY Investigators, Huang, Y., Li, J., Zhu, X., Sun, J., Ji, L., Hu, D., Pan, C., Tan, W., Jiang, S., et al. (2017) · Acta Diabetologica

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk Factors

Cited by 21

Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes

Luo, Y., Paul, S. K., Zhou, X., Chang, C., Chen, W., Guo, X., Yang, J., Ji, L., & Wang, H. (2017) · Journal of Diabetes Research

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 13

A Roadmap to an Equitable Digital Diabetes Ecosystem

Kerr, D., Klonoff, D. C., Bergenstal, R. M., Choudhary, P., & Ji, L. (2023) · Endocrine Practice

Diabetes Management and ResearchMobile Health and mHealth Applications

Cited by 10

Machine learning for the prediction of atherosclerotic cardiovascular disease during 3‐year follow up in Chinese type 2 diabetes mellitus patients

Ding, J., Luo, Y., Shi, H., Chen, R., Luo, S., Yang, X., Xiao, Z., Liang, B., Yan, Q., Xu, J., et al. (2023) · Journal of Diabetes Investigation

Artificial Intelligence in HealthcareMachine Learning in Healthcare

Cited by 9